Format

Send to

Choose Destination
World J Surg. 2016 Dec;40(12):3080-3087. doi: 10.1007/s00268-016-3705-9.

A Majority of Admitted Patients With Ruptured Abdominal Aortic Aneurysm Undergo and Survive Corrective Treatment: A Population-Based Retrospective Cohort Study.

Author information

1
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. rebecka.hultgren@karolinska.se.
2
Department of Vascular Surgery A2:01, Karolinska University Hospital, Stockholm, Sweden. rebecka.hultgren@karolinska.se.
3
Section for Vascular Surgery, Department of Surgery, Södersjukhuset, Stockholm, Sweden.
4
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
5
Department of Vascular Surgery A2:01, Karolinska University Hospital, Stockholm, Sweden.

Abstract

BACKGROUND:

Abdominal aortic aneurysm (AAA) is an asymptomatic, potentially lethal condition predominantly found in elderly. The mortality is 100 % if rupture occurs and left untreated, but even in treated patients the mortality is substantial. Female sex and treatment with open repair rather than endovascular aortic repair (EVAR) have been reported to negatively affect outcome. The objective was to describe the contemporary care and outcome of all treated and untreated patients with ruptured AAA (rAAA) admitted to hospital.

METHOD:

Population-based retrospective investigation, including all patients admitted to the emergency departments within Stockholm County diagnosed with rAAA 2009-2013. All identified patients' charts (n = 297) were analyzed; the study cohort includes 283 verified patients.

RESULTS:

Men were in majority [214 (76 %), 69 (24 %) women] and were younger than women (78 vs 82 years, p < 0.001). A majority of patients were treated (212/283, 75 %), a similar proportion of women and men. Untreated patients had a higher mean age (84 vs 77 years, p < 0.001). The proportion treated with EVAR was 27 %, and they were older than OR treated (79 vs 76 years, p = 0.043). Forty-seven percentage of patients admitted with rAAA survived 30 days, and 62 % of treated patients survived 30 days. The 30-day mortality for women and men was similar.

CONCLUSIONS:

Our results and other contemporary series show a shift toward a higher rate of treated patients with rAAA, and improving outcomes, similar for women and men. The increased use of EVAR contributes to this improvement in short-term outcome. High age influences the willingness to treat patients with rAAA.

PMID:
27549597
PMCID:
PMC5104803
DOI:
10.1007/s00268-016-3705-9
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center